Abstract
1 million people are predicted to get infected with Lyme disease in the USA in 2018. Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected with Lyme disease in Europe in 2018. In the USA by 2050, 55.7 million people (12% of the population) will have been infected with Lyme disease. In Europe by 2050, 134.9 million people (17% of the population) will have been infected with Lyme disease. Most of these infections will, unfortunately, become chronic. The estimated treatment cost for acute and chronic Lyme disease for 2018 for the USA is somewhere between 4.8 billion USD and 9.6 billion USD and for Europe somewhere between 10.1 billion EUR and 20.1 billion EUR. If governments do not finance IV treatment with antibiotics for chronic Lyme disease, then the estimated government cost for chronic Lyme disease for 2018 for the USA is 10.1 billion USD and in Europe 20.1 billion EUR. If governments in the USA and Europe want to minimize future costs and maximize future revenues, then they should pay for IV antibiotic treatment up to a year even if the estimated cure rate is as low as 25%. The cost for governments of having chronic Lyme patients sick in perpetuity is very large.
Highlights
The objectives of this article are to investigate the incidence rate of Lyme disease in the USA and Europe, to investigate the financial cost of chronic Lyme disease and to find the most cost-efficient way for the governments to solve the current chronic Lyme disease pandemic [1]
According to one scientific study [128], that can be found on the Centers for Disease Control and Prevention (CDC) website and published in Clinical Infectious Diseases which is a “scientific” journal issued by the Infectious Diseases Society of America (IDSA) 2.4 million individual Lyme disease blood tests were done in the USA 2008
If someone acknowledges that acute Lyme disease is caused by bacteria, they are forced by logical reasoning to acknowledge that chronic Lyme disease is caused by bacteria because the immune system by itself can never eradicate a Borrelia infection and a bacterial infection does not magically disappear without antibiotic treatment once a person has been infected
Summary
The objectives of this article are to investigate the incidence rate of Lyme disease in the USA and Europe, to investigate the financial cost of chronic Lyme disease and to find the most cost-efficient way for the governments to solve the current chronic Lyme disease pandemic [1]. IDSA represents infectious disease doctors that firmly believe that all Lyme disease infections, regardless of whether the infection is acute or chronic, can successfully and be treated with three weeks of oral antibiotic [8] despite the fact that no scientific studies currently exist that support the claim that three weeks of oral antibiotics can always cure acute or chronic Lyme disease [9] and there exist many scientific studies that have shown that the Borrelia bacteria can survive three weeks of oral antibiotics in vitro [10,11] and in vivo, in mice [12,13,14,15], dogs [16], horses [17], monkeys [18] and in humans [19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36]. The immune system by itself can never eradicate a Borrelia infection [41,42,43,44] and no scientific studies exist that show that
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
